Screener
Iovance Biotherapeutics, Inc. IOVA Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.86B.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s market capitalization?
- Iovance Biotherapeutics, Inc. (IOVA) reported market capitalization of $1.86B in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s market capitalization changed year-over-year?
- Iovance Biotherapeutics, Inc.'s market capitalization increased by 195.9% year-over-year, from $627.8M to $1.86B.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s market capitalization has grown at a -30.8% compound annual growth rate (CAGR), from $6.84B to $1.08B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Iovance Biotherapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude